Foghorn Therapeutics  logo
Foghorn Therapeutics FHTX
$ 7.87 0.13%

Quarterly report 2024-Q3
added 11-04-2024

report update icon

Foghorn Therapeutics Cash Flow 2011-2024 | FHTX

Annual Cash Flow Foghorn Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

-118 M 194 M -50.2 M -31.3 M -46.3 M - - - - - - - -

Depreciation & Amortization

3.45 M 3.32 M 3.23 M 1.33 M 693 K - - - - - - - -

Accounts Payables

6.26 M 5.41 M 3.82 M 3.68 M - - - - - - - - -

Accounts Receivables

- - - - - - - - - - - - -

Total Inventories

- - - - - - - - - - - - -

All numbers in USD currency

Quarterly Cash Flow Foghorn Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

- - -29.3 M - - - -31.2 M - 223 M 243 M 272 M - -62.1 M -41.6 M -23.1 M - -20.6 M -23.4 M -10.8 M - -33.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Depreciation & Amortization

700 K 800 K 835 K - 900 K 800 K 859 K - 900 K 800 K 811 K - 800 K 800 K 772 K - 300 K 200 K 255 K - 460 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Payables

3.45 M 4.81 M 5.63 M 6.26 M 6.5 M 6.93 M 7.29 M 5.41 M 5.26 M 3.64 M 5.07 M 3.82 M 3.82 M 3.41 M 2.91 M 3.68 M 3.68 M 3.68 M 3.68 M 3.44 M 3.44 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Receivables

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Inventories

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency